Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Respirology (Carlton, Vic.)|May 26, 2017
Modified GAP index for prediction of acute exacerbation of idiopathic pulmonary fibrosis in non-small cell lung cancerHaruki Kobayashi, Shota Omori, Kazuhisa Nakashima, et al.
International Journal of Clinical Oncology|April 7, 2017
Response to the treatment immediately before nivolumab monotherapy may predict clinical response to nivolumab in patients with non-small cell lung cancerHaruki Kobayashi, Shota Omori, Kazuhisa Nakashima, et al.
Nutrition and Cancer|January 29, 2019
Platinum Combination Chemotherapy Is Poorly Tolerated in Malnourished Advanced Lung Cancer Patients with Poor Performance StatusTakayuki Fujio, Kazuhisa Nakashima, Tateaki Naito, et al.
Journal of the American Chemical Society|July 30, 2024
Synthesis of Z-gem-Cl,CF3-Substituted Alkenes by Stereoselective Cross-Metathesis and the Role of Disubstituted Mo AlkylidenesQinghe Liu, Can Qin, Jing Wan, et al.
BMC Cancer|August 4, 2019
Acquired immunodeficiency associated with thymoma: a case reportTakahisa Kawamura, Tateaki Naito, Haruki Kobayashi, et al.
Lung Cancer (Amsterdam, Netherlands)|January 2, 2022
Phase 1b study of ramucirumab in combination with irinotecan plus cisplatin in chemo-naïve patients with extensive-stage small-cell lung cancerHirotsugu Kenmotsu, Keita Mori, Risa Mizuno, et al.
International Journal of Clinical Oncology|July 5, 2025
Phase II study of afatinib for advanced non-small cell lung cancer with uncommon epidermal growth factor receptor mutations, including compound mutations detected by next-generation sequencingNobuaki Mamesaya, Keita Mori, Haruki Kobayashi, et al.
Lung Cancer (Amsterdam, Netherlands)|June 3, 2018
ILD-NSCLC-GAP index scoring and staging system for patients with non-small cell lung cancer and interstitial lung diseaseHaruki Kobayashi, Tateaki Naito, Katsuhiro Omae, et al.
Clinical Lung Cancer|July 5, 2023
Continuous vs. Fixed 2-year Duration Immune Checkpoint Inhibitor Treatment of Patients With Non-Small Cell Lung Cancer: A Single Institution Database AnalysisHaruki Kobayashi, Kazushige Wakuda, Tateaki Naito, et al.
Investigational New Drugs|July 5, 2018
Leptomeningeal recurrence after long-term alectinib therapy for non-small cell lung cancer harboring an EML4-ALK fusion proteinTakahisa Kawamura, Haruyasu Murakami, Haruki Kobayashi, et al.
Pageof 9